ask="N/A"
ask_size="N/A"
average_daily_volume="183930"
bid="17.65"
bid_size="2100"
book_value="6.18"
change="-0.95"
change_from_200_day_moving_average="2.30"
change_from_50_day_moving_average="-0.81"
change_from_52_week_high="-4.35"
change_From_52_week_low="7.60"
change_in_percent="-4.55%"
close="19.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.18"
ebitda="-77.73M"
eps_estimate_current_year="-3.60"
eps_estimate_next_quarter="-0.93"
eps_estimate_next_year="-3.40"
ex_dividend_date="N/A"
float_shares="18536000"
high="21.10"
high_52_weeks="24.30"
last_trade_date="3/2/2017"
last_trade_price="19.95"
last_trade_size="7724"
last_trade_time="4:00pm"
low="19.70"
low_52_weeks="12.35"
market_capitalization="571.53M"
moving_average_200_day="17.65"
moving_average_50_day="20.76"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="39.67"
open="20.75"
pe_ratio="N/A"
peg_ratio="-0.50"
percent_change_from_200_day_moving_average="+13.06%"
percent_change_from_50_day_moving_average="-3.89%"
percent_change_from_52_week_high="-17.90%"
percent_change_from_52_week_low="+61.54%"
previous_close="20.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.38"
price_per_sales="1995.81"
revenue="300000.00"
shares_outstanding="28648000"
short_ratio="28.66"
stock_exchange="NGM"
symbol="RVNC"
volume="212670"
weeks_range_52="12.35 - 24.30"
